sees fy adjusted earnings per share $4.10 to $4 20.20.
sees fy adjusted earnings per share $3.18.
qtrly consolidated sales of $1.67 billion, a new high in fourth consecutive year.
q2 sales $393 million versus refinitiv ibes estimate of $383 million.
sees 2021 adjusted ebitda margin in range of 12% to 14%.
compname reports q2 2021 results and announces 20% decrease in recordable cases compared to q2 2020.
sees fy operating profit of about $161 million.
compname reports q2 adjusted ebitda of $200 million versus refinitiv ibes estimate of $207 million.
qtrly sales of $168 million versus refinitiv ibes estimate of $178.5 million.
qtrly ebitda margin of 12.6% to 12.7%.
q4 sales $130 million versus refinitiv ibes estimate of $107 million.
sees 2020 adjusted ebitda excluding jcc to be in range of $211 million to $212 million.
qtrly adjusted earnings per share $3.8.
qtrly total debt was $784 million as of december 31, 2020, as of june 30, 2020.
qtrly adjusted ebitda for rups was $10 million, same as prior year.
qtrly u.s. plant employees had 99% of all infections, up from 99% last year.
